- Lifeuntox
- Posts
- The Deworming Drugs Big Pharma Doesn't Want You Asking About (1)
The Deworming Drugs Big Pharma Doesn't Want You Asking About (1)
Lifeuntox Daily
March 16, 2026
Good morning, wellness warriors!
Three drugs. Pennies per dose. Decades of safety data. And a growing mountain of research suggesting they might be some of the most promising cancer-fighting compounds science has overlooked not because they don’t work, but because nobody can patent them.
Today we’re pulling back the curtain on ivermectin, fenbendazole, and mebendazole - three antiparasitic drugs that are quietly generating some of the most exciting preclinical cancer research in modern medicine. This is the story Big Pharma would rather you never heard.
What’s brewing in today’s edition:
📸 Ivermectin: Nobel Prize-winning drug showing powerful antitumor effects across multiple cancer types
🔬 Fenbendazole: The veterinary dewormer with case reports of stage IV cancer remission
💊 Mebendazole: FDA-approved, blood-brain barrier crossing, and in active clinical trials
💡 What to actually do with this information (and what NOT to do)
Share the wellness wisdom: Forward to someone you care about (copy URL here).
📸 IVERMECTIN
THE NOBEL PRIZE WINNER THEY WANT YOU TO FORGET
Let's start with what ivermectin actually is. Developed in the late 1970s, it earned its discoverers - Satoshi Ōmura and William C. Campbell - the 2015 Nobel Prize in Physiology or Medicine for transforming the treatment of parasitic diseases like river blindness and elephantiasis. It's been safely administered to hundreds of millions of people worldwide. That safety profile matters enormously.
Now here's where it gets interesting. A growing body of preclinical research published in peer-reviewed journals has found that ivermectin demonstrates anticancer effects across more than 20 tumour types, including breast, colon, lung, pancreatic, and blood cancers. A comprehensive review in Pharmacological Research found that ivermectin inhibits cancer cell growth, triggers programmed cell death (apoptosis), and disrupts key cancer-driving pathways including Wnt/β-catenin and Akt/mTOR signalling.
A January 2025 study published in Anticancer Research showed that ivermectin combined with recombinant methioninase synergistically eradicated pancreatic cancer cells — reducing viability by 80% compared to 45% with ivermectin alone. Pancreatic cancer has a devastating 10% five-year survival rate, so any promising lead should be vigorously pursued.
Meanwhile, the National Cancer Institute confirmed in early 2025 that it had conducted its own preclinical evaluation of ivermectin's ability to kill cancer cells, with NCI Director Anthony Letai stating the institute is "taking it seriously."
💡 Key Insight: Ivermectin modulates multiple cancer pathways including Wnt/β-catenin, PI3K/Akt/mTOR, and STAT3 and has shown efficacy in preclinical models across breast, colon, lung, pancreatic, and blood cancers. Yet no large-scale randomised controlled trials in humans have been funded.
Here's the uncomfortable truth: ivermectin is off-patent, costs pennies per dose, and can't generate the billions that a novel patented drug can. A 2025 review in Current Oncology Reports acknowledged the promising preclinical data but highlighted a critical "translational gap" - meaning the pharmaceutical industry has little financial incentive to fund the expensive human trials needed to prove what lab studies are already suggesting. This is the core problem with drug repurposing for cancer: the science is promising, but the profit motive isn't there.
⚠️ Important: While preclinical data is compelling, no large-scale human clinical trials have confirmed ivermectin's effectiveness against cancer. Self-medication without medical supervision is dangerous and can cause toxicity. Always consult your healthcare provider before considering any off-label drug use.
— TOGETHER WITH HEAVENLY HEAT SAUNAS —
Detox From The Inside Out — Without Adding More Toxins
Most infrared saunas are built with plywood, toxic adhesives, and cheap components that off-gas volatile organic compounds the moment they heat up — the exact opposite of what a detox tool should do.
Heavenly Heat Saunas has been building the cleanest saunas in the world since 1988 — using 100% natural Canadian hemlock wood, zero glues or adhesives, and ultra-low EMF/ELF heaters that are independently tested and verified.
Trusted by environmental health clinics and chemical sensitivity specialists for over 35 years, these hand-built saunas deliver deep infrared heat, optional red light therapy, and a 10-year warranty. If you're serious about detox, make sure your sauna isn't adding to the toxic burden.
Vetted by our clinical research & toxicologist team. This is a sponsored partnership — purchases through our link support the Lifeuntox mission.
🔒2 More Drugs: Premium Members Only
🔬 FENBENDAZOLE: The Veterinary Drug That's Starving Cancer Cells
The Joe Tippens case that went viral. How it disrupts cancer cell energy metabolism through inhibition. 2024-2025 studies showing it targets both cancer cells AND drug-resistant cancer stem cells.
Includes: Mechanism of action • Key studies • p53 activation pathway • American Cancer Society statement • Safety warnings
💊 MEBENDAZOLE: The $0.50 Dewormer Johns Hopkins Is Studying for Cancer
The only antiparasitic with multiple human clinical trials for cancer. Crosses the barrier — making it uniquely promising for brain tumours. Case studies showing complete remission of metastases.
Includes: Johns Hopkins research • Phase 1 trial results • Case studies with dosages • 63% survival increase in mice • Blood-brain barrier science
✉️ COMMUNITY CORNER
Your Questions & Feedback From Recent Newsletters
“Rest is something i value ( who doesn't love a good nap) but sometimes forget it shouldn't come because i "earned" it. Thanks for the reminder!”
“So much pertinent information! Helps make decision making easier when you know what to look for.”
“The Clean Edit has become my favorite read of the week. Clean living and eating can be so overwhelming. I've been researching cleaner brands for years but I am so appreciative of the options you give us every week. Thank you! ”
🔓 Get the Full 3-Drug Research Report + Action Plan
You just learned about ivermectin. Now get the complete analysis of all three drugs, including the one with actual human clinical trials and case studies showing complete remission.
✦ Fenbendazole deep dive — mechanisms, Joe Tippens case, 2024-2025 studies
✦ Mebendazole deep dive — Johns Hopkins research, clinical trial results, case studies
✦ Drug comparison table — all mechanisms, approvals, and evidence levels
✦ 5-step action plan — how to bring this to your doctor
✦ ClinicalTrials.gov links — track recruiting studies
✦ 500+ toxic ingredient Blacklist database
✦ 50+ exclusive discount codes in the Savings Vault
🛡️ 30-day money-back guarantee. No questions asked.
💡 HEALTH HACK OF THE DAY
The “Medical Advocate” File: Create a dedicated folder — digital or physical — where you keep every piece of medical research that resonates with you. Print the key studies. Write down your questions. Bring it to your next doctor’s appointment. The patients who get the best outcomes are the ones who show up informed, respectful, and prepared. Your doctor isn’t your adversary — but they’re also not going to spend hours reading emerging research on repurposed drugs. That’s your job. Be your own best advocate.
⭐ RATE TODAY’S EDITION
How Was Today's Edition? |
📝 Got questions, feedback, or aha moments?
Reply to this email with your thoughts, questions, or responses for a chance to be featured in tomorrow's Community Corner! We read every single email and love hearing your breakthroughs, struggles, and everything in between.
This material is provided solely for informational purposes and is not providing or undertaking to provide any medical, nutritional, behavioral or other advice or recommendation in or by virtue of this material. This newsletter is for general informational purposes only and does not constitute the practice of medicine, nursing or other professional health care services, including the giving of medical advice, and no doctor/patient relationship is formed. The use of information on this newsletter or materials linked from this newsletter is at the user’s own risk. The content of this newsletter is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Users should not disregard, or delay in obtaining, medical advice for any medical condition they may have, and should seek the assistance of their health care professionals for any such conditions.